Thank you Andy. After doing some research today, I bought 2 contracts of Jan 2019 $47.50 Calls on FMI. Good luck!
-Gaurav
1 Like
bulwnkl
Thanks for this idea. Since the stock was up today and pricing for the $47.50 calls was increasing, I purchased January 2018 calls at strikes of $47.50, $50.00, and $52.50 so I was able to spread out my capital invested.
Thanks for the tip.
Do you have thoughts on the patent infringement lawsuit recently filed by Caris Life:
https://www.genomeweb.com/molecular-diagnostics/caris-life-s…
2K10
2 Likes
I’m not sure how much validity or damages there are. Fortunately, it’s a false advertising lawsuit not a patent lawsuit dealing with infringement or theft of IP. My guess is that however the case goes its affect will pail in comparison to the Medicare/Medicaid reimbursement decision.
From what I have read FMI is far ahead of all competitors in terms of methodology and genomic data. I think that is key. I think the fact that they are under serious for massive reimbursement is a testament to where they are at vs. competitors.
Best,
bulwnkl (aka Brian)
1 Like
Sorry the previous link looks like it was behind a paywall but hopefully this one isn’t. It calls it a patent infringement lawsuit and seems to go to the heart of what we are hoping would be approved by Medicare:
https://www.prnewswire.com/news-releases/caris-life-sciences…
3 Likes
I am a retired lawyer who spent his career specializing in patent litigation, though I did not do much in the biotech arena. This appears to be a serious patent case brought by a highly reputable patent firm that litigates more patent cases than any other firm in the country. I think it needs to be taken seriously, particularly since it was just filed, will be next to impossible to handicap since the devil will be in the details that none of us has access to, and probably will take years to resolve. So, you have to assume it presents a high risk to the FMI business at this point. More than that I cannot say at this point.
11 Likes
I saw a suit on false advertising, but did not initially see a patent case. I missed that. If you get a chance to dig into the details, I’d love to hear your thoughts. Thanks.
buwlnkl
Need to bump this so that it is easier to find the thread and give bulwnkl his extremely well-deserved props.
5 Likes
Having read through this Citron short report about Exact Sciences (EXAS), it sounds like FMI and EXAS play in basically the same market.
http://citronresearch.com/exact-sciences-corp-we-admit-to-be…
This Citron thesis seems to have a lot more logic behind it than the Hubspot, Shopify, and Ubiquiti “theses”. If Citron is correct in this case, it may be partially due to the efficacy of FMI’s testing in addition to CellMax Life. Either way, it is an interesting space to look at.
Well, looking back at this idea, buying shares would been more than a double now with shares about $103, options percentage gains even more, for those who understand them enough to be comfortable using them 
I (only slightly) sadly haven’t held any FMI options positions for a few months now, after selling the Aug $75 call position for around $14.00 or $15.00 after buying at $6.40 (per another old post of mine on this board). So, I could have had more than a double from then… if I had endured a pretty huge drop in the interim.
Regardless, this was a great one to bring to the board, and bulwnkl is a poster to pay close attention to if am idea is presented (see also: Kite, which I missed before it was bought out).
volfan84
No present FMI position and no plans to initiate one in the near future
3 Likes
I am still holding my shares and options. I purchased $50.00 calls (January 2018 expiration) when Bulwnkl initially presented FMI in November 2017. I then added $75 calls (also January 2018 expiration) in December 2017. I exercised 60% of the $50 calls into shares and sold the other 40%; the $75 calls expired worthless. In total, I netted a 14% profit on those calls.
I set up a $67.50 synthetic long (8/17/18 expiration) in January 2018, for a net credit of $0.80/share; that position is worth $33.17/share. I am considering selling some of those calls to cover the purchase costs of exercising the remaining calls at $67.50. I expect the puts to expire worthless in August.
Of course I am still holding shares acquired at a strike of $50.00 purchased in January.
Overall I am quite pleased with this position.
Thanks again to Bulwnkl!!
1 Like
Well, Roche is paying $137/share. Great idea to be brought to the board by bulwnkl.
Roche to buy rest of Foundation Medicine https://seekingalpha.com/news/3364769?source=ansh $RHHBY, $FMI, $RHHBF
I (only slightly) sadly haven’t held any FMI options positions for a few months now, after selling the Aug $75 call position for around $14.00 or $15.00 after buying at $6.40 (per another old post of mine on this board). So, I could have had more than a double from then… if I had endured a pretty huge drop in the interim.
Circling back, guess this is an instance where I could have been better off buying shares at about $50 when the idea was first presented fo the board…or at least held the Aug $75 call position longer. That would be worth about $37 + $25 = $62.00 per contract now.
volfan84
No FMI position, congrats to all on the board who still had one
5 Likes
Nice job!
I had started eyeballing this again recently. Too late to the party!
Darn. Was hoping FMI would turn into the gatekeeper for IO. I re-bought at 73.60 in late April so almost a double but guess in the back of my mind I figured Roche would buy the rest eventually. Now I know how Ant feels as many of his picks eventually get purchased.
Rob
Bulwnkl,
First you bring us KITE, then you bring us FMI. I know that’s a small sample size but what a brilliant track record. I have profited handsomely from both. Thank you for the initial sharing and also the education along the way!!!
4 Likes
Thanks for the kind words volfan84. I have been focusing on my daughter’s high school graduation and mentoring her InvenTeam project so I haven’t been very active. I am sitting in a MIT dorm room getting ready for a presentation as I write.
Anyway, FMI was another high probability, binary event that was definitely worth a stock purchase after the insurance approval. I wish they would have remained independent, but can’t complain about my return on this.
I am very appreciative of this board and the efforts made to share stock ideas. I think the best way to say thank you is for me to provide an idea once in a while.
That said, I don’t want to contribute to the congestion so I try to limit what I post to things that I think are absolutely helpful. I am glad this helped some of you.
Best,
bulwnkl
11 Likes
Thanks for the kind words utahchris
I have been focusing on my daughter’s high school graduation and mentoring her InvenTeam project so I haven’t been very active. I am sitting in a MIT dorm room getting ready for a presentation as I write.
Wow. Good luck.
Seriously OT, but thanks. I guess I will use today’s news as an excuse to be a little self indulgent.
If anyone is interested in a great high school program, Google
Lemelson-MIT InvenTeam
We are the last team on the list: Team Ignite
My daughter organized the team, and the idea she worked out with an orphanage in Zambia was selected as one of the top 15 out of 300 inventions submitted nationwide. Her team received a$10,000 grant to develop the idea.
Presentation is tomorrow:). I am one of the team’s engineering mentors.
We are supposed to do what we can to publicize the project. There are details online.
Best,
Bulwnkl
13 Likes
I guess I will use today’s news as an excuse to be a little self indulgent.
Oh you earned it! Nothing makes you so proud and happy, as a parent, to see our kids shine. Congratulations on winning that grant. I know it is a great honor.
3 Likes